The present invention discloses compounds according to Formula I: Wherein Cy, R1, L1, R3, R4, R5, La, and Ra are as defined herein. Novel benzimidazoles according to Formula I, able to inhibit JAK are disclosed, these compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic diseases, inflammatory diseases, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or hypersecretion of interferons.本發明揭示式I化合物:其中Cy、R1、L1、R3、R4、R5、La及Ra如本文所定義。揭示能夠抑制JAK之新穎的式I之苯并咪唑,此等化合物可製備為醫藥組合物,且可用於預防及治療哺乳動物(包括人類)之多種病狀,包括作為非限制性實例之過敏性疾病、發炎疾病、自體免疫疾病、增生性疾病、移植排斥反應、涉及軟骨轉換障礙之疾病、先天性軟骨畸形及/或與IL6分泌過多或干擾素分泌過多相關聯之疾病。